SOURCE: Genmed Holding Corp.

Genmed Holding Corp.

April 12, 2011 10:43 ET

Genmed Holding Corp. CEO Featured in Business Focused Publications

HOLLYWOOD, CA--(Marketwire - Apr 12, 2011) - Erwin Bouwens, CEO of Genmed Holding Corp. (OTCBB: GENM), begins the first in a series of interviews with business focused print and online publications to further introduce the core competencies of Genmed Holding Corp. and their global initiative to provide high-quality generic pharmaceuticals to the world market.

Bouwens is enthusiastic to share the message of Genmed's business model, to register, distribute and market vital generic medicines to immerging territories that are in need of vital medicines.

The first in this series of interviews begins today at 1:30 PDT with CEO CFO Magazine. Additional interviews with business publications will be seen in the coming weeks.

Genmed Holding Corp. and its principals are working to reinforce the messaging of the ongoing international public awareness campaign featuring Academy Award Nominated actor, Eric Roberts. The campaign, which spans across multiple media platforms, is both informative and uniquely entertaining, as Roberts delivers a heart-felt message in the company's Video News Release.

If you are interested in learning more about this innovative company, please reference their stock symbol GENM or visit the Genmed website at www.genmed.nl.

About Genmed Holding Corp.

Genmed Holding Corp. is a fully reporting publicly traded company that trades on the OTC under the symbol GENM. It is a United States and Dutch based company focusing on the delivery of low cost generic pharmaceutical drugs directly to distribution channels throughout the world. The Company began its generic drug business in 2008 and today operates primarily through its 100% owned subsidiary Genmed B.V., which is registered in the Netherlands. The Company is led by an experienced management team and board who have considerable and highly relevant experience in product development, registration, sales, marketing, distribution, operations, and financial administration.

For Additional Information, Go to the Website: www.genmed.nl

This press release contains certain "forward-looking statements" within the meaning of federal securities laws including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions. Although the Company believes that the statements were reasonable when made, these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: competitive and general economic conditions, adverse effects of litigation, the timely development and acceptance of our products and services, significant changes in the competitive environment, the failure to generate or the loss of significant numbers of customers, the loss of senior management or increased government regulations.